SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-181830
Filing Date
2005-09-08
Accepted
2005-09-08 06:46:37
Documents
8
Period of Report
2005-09-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22343
2 CERTIFICATE OF OWNERSHIP AND MERGER OF REGISTRANT dex31.htm EX-3.1 10886
3 SPECIMEN COMMON STOCK CERTIFICATE OF REGISTRANT dex41.htm EX-4.1 696
4 PRESS RELEASE DATED SEPTEMBER 6,2005 dex991.htm EX-99.1 18441
5 GRAPHIC g28185image001.jpg GRAPHIC 519827
6 GRAPHIC g28185image002.jpg GRAPHIC 17202
7 GRAPHIC g28185image003.jpg GRAPHIC 1124
8 GRAPHIC g28185image004.jpg GRAPHIC 134625
  Complete submission text file 0001193125-05-181830.txt   981703
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30369 | Film No.: 051074117
SIC: 2835 In Vitro & In Vivo Diagnostic Substances